Health Canada approves drug that treats hot flashes for use by breast cancer patients – CTV News

Health Canada approves drug that treats hot flashes for use by breast cancer patients  CTV NewsMuna Al-Khaifi: A New Non-Hormonal Option for Vasomotor Symptoms in Breast Cancer Survivors  OncodailyLYNKUET® (elinzanetant) Receives Expanded Market Authorization in Canada for Treatment of Moderate to Severe Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy (AET) Related to Breast Cancer  Business WireHealth Canada’s nod brings hope for breast cancer patients  Winnipeg SunMHRA authorizes Bayer’s Lynkuet for wider VMS use  The Pharma Letter